Ruiyang Xie

49 North Garden Road
Beijing, 100191, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Clinicopathological features and prognostic factors associated with long-term survival (≥5 years) in patients with clear cell renal cell carcinoma and venous tumor thrombus

Clinicopathological features and prognostic factors associated with long-term survival (≥5 years) in patients with clear cell renal cell carcinoma and venous tumor thrombus

Journal: Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences

Published: July 23, 2026

Segmental versus non-segmental inferior vena cava resection during robot-assisted radical nephrectomy and thrombectomy: an overlap-weighted analysis.

Segmental versus non-segmental inferior vena cava resection during robot-assisted radical nephrectomy and thrombectomy: an overlap-weighted analysis.

Journal: World journal of urology

Published: July 11, 2026

Long-term follow-up of third generation anti-CD30 CAR T-cell therapy in relapsed/refractory CD30+ lymphomas: a single-arm, multicentre, phase 1-2 trial.

Long-term follow-up of third generation anti-CD30 CAR T-cell therapy in relapsed/refractory CD30+ lymphomas: a single-arm, multicentre, phase 1-2 trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: April 06, 2026

Renal Pelvic Urothelial Carcinoma With Venous Tumor Thrombus: Prognosis and Reconsideration of TNM Staging.

Renal Pelvic Urothelial Carcinoma With Venous Tumor Thrombus: Prognosis and Reconsideration of TNM Staging.

Journal: Clinical genitourinary cancer

Published: September 28, 2025

Bioprinting of patient-derived heterogeneous renal cell carcinoma organoids for personalized therapy.

Bioprinting of patient-derived heterogeneous renal cell carcinoma organoids for personalized therapy.

Journal: Biofabrication

Published: May 05, 2025

Clinical, pathological, and prognostic features of invasive pyelocaliceal urothelial carcinoma with venous thrombus: A propensity score-matched retrospective cohort study.

Clinical, pathological, and prognostic features of invasive pyelocaliceal urothelial carcinoma with venous thrombus: A propensity score-matched retrospective cohort study.

Journal: Asian journal of urology

Published: October 11, 2024

Dynamic Changes in Serum Immunoglobulin G Predict Clinical Response and Prognosis in Metastatic Clear-cell Renal Cell Carcinoma.

Dynamic Changes in Serum Immunoglobulin G Predict Clinical Response and Prognosis in Metastatic Clear-cell Renal Cell Carcinoma.

Journal: European urology open science

Published: October 03, 2024

Safety and efficacy of intravesical Bacillus Calmette-Guerin instillation for superficial recurrence following bladder-sparing therapy of muscle invasive bladder cancer: A retrospective study.

Safety and efficacy of intravesical Bacillus Calmette-Guerin instillation for superficial recurrence following bladder-sparing therapy of muscle invasive bladder cancer: A retrospective study.

Journal: Urologic oncology

Published: September 24, 2024

Predictive Value of Neutrophil Extracellular Traps in Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer.

Predictive Value of Neutrophil Extracellular Traps in Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer.

Journal: Molecular carcinogenesis

Published: August 15, 2024

Efficacy and safety of systemic treatment for progressive and refractory desmoid tumor: a systematic review and Bayesian network meta-analysis.

Efficacy and safety of systemic treatment for progressive and refractory desmoid tumor: a systematic review and Bayesian network meta-analysis.

Journal: Discover oncology

Published: March 15, 2024

Neutrophil extracellular traps in relationship to efficacy of systemic therapy for metastatic renal cell carcinoma.

Neutrophil extracellular traps in relationship to efficacy of systemic therapy for metastatic renal cell carcinoma.

Journal: Cancer medicine

Published: September 13, 2023

Hematologic side effects of immune checkpoint inhibitor with or without chemotherapy in patients with advanced and metastatic gastrointestinal cancer: A systematic review and network meta-analysis of phase 3 trials.

Hematologic side effects of immune checkpoint inhibitor with or without chemotherapy in patients with advanced and metastatic gastrointestinal cancer: A systematic review and network meta-analysis of phase 3 trials.

Journal: Frontiers in pharmacology

Published: February 11, 2023

Showing 1-12 of 21

Last Updated: 09/26/2026